the 14 PRESCRIPTION: Germany’s Two Cannabis Models, Telemedicine, and Hidden Economics of Local Pharmacy

What can a 14 medical invoice reveal about an entire healthcare system?In Germany, a digital consultation can connect a private patient, a physician, a prescription and a licensed pharmacy. That route sits beside a very different non-medical cannabis regime-one that permits possession, home cultivation and cultivation associations but does not create a conventional national retail market.The 14 Prescription follows these parallel systems and then follows the money. It asks whether lawful self-paid medical demand can contribute to pharmacy capacity and other shared healthcare infrastructure, particularly where transaction volume is thin. It also confronts the opposite possibility: digital platforms may concentrate business in specialist mail-order pharmacies while making medical judgement dangerously easy to commercialise.Current to 22 August 2026, this short policy book distinguishes enacted rules from pending reforms and examines the July 2026 removal of dried cannabis flowers from the special medicinal-cannabis benefit under section 31(6) SGB V. It treats the case for access and the case for restraint with equal seriousness.For readers interested in healthcare finance, telemedicine, pharmacy policy, cannabis regulation and the institutional consequences of digital markets.